Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Total Debt: 2017-2023

Historic Total Debt for Organogenesis Holdings (ORGO) over the last 7 years, with Dec 2023 value amounting to $66.2 million.

  • Organogenesis Holdings' Total Debt fell 8.11% to $62.1 million in Q3 2024 from the same period last year, while for Sep 2024 it was $256.7 million, marking a year-over-year decrease of 7.40%. This contributed to the annual value of $66.2 million for FY2023, which is 6.41% down from last year.
  • Latest data reveals that Organogenesis Holdings reported Total Debt of $66.2 million as of FY2023, which was down 6.41% from $70.8 million recorded in FY2022.
  • Over the past 5 years, Organogenesis Holdings' Total Debt peaked at $76.7 million during FY2020, and registered a low of $44.6 million during FY2019.
  • Moreover, its 3-year median value for Total Debt was $70.8 million (2022), whereas its average is $70.1 million.
  • In the last 5 years, Organogenesis Holdings' Total Debt skyrocketed by 73.53% in 2019 and then fell by 6.41% in 2023.
  • Organogenesis Holdings' Total Debt (Yearly) stood at $44.6 million in 2019, then reached $44.7 million in 2019, then reached $54.6 million in 2019, then spiked by 73.53% to $54.6 million in 2019, then skyrocketed by 40.33% to $76.7 million in 2020, then declined by 4.23% to $73.4 million in 2021, then declined by 3.62% to $70.8 million in 2022, then dropped by 6.41% to $66.2 million in 2023.